Prevention and Treatments of Cardiovascular Diseases
A special issue of Applied Sciences (ISSN 2076-3417). This special issue belongs to the section "Applied Biosciences and Bioengineering".
Deadline for manuscript submissions: closed (15 April 2022) | Viewed by 23636
Special Issue Editor
Interests: insulin resistance; diabetes; obesity; metabolic syndrome; multiple sclerosis; cardiovascular disease; cholesterol; cardiovascular epidemiology; diabetes mellitus type 2; cardiovascular genetics
Special Issue Information
Dear Colleagues,
Cardiovascular diseases (CVDs) are the leading cause of death globally and present an increasing strain on healthcare systems. CVDs are multifactorial and often require several treatment options, including drastic lifestyle changes. Emerging research has focused on the use of novel biomarkers, such as miRNAs, to pre-empt the development of CVDs. The incidence of diabetes has increased significantly over the past 20 years and is expected to continue this upward trajectory. Cases of diabetes have been recorded in younger populations and in countries previously reporting low incidences of the disease. Prevention and treatment options are imperative to curb the rapidly increasing incidence of CVDs, especially in previously low-risk populations.
For this Special Issue, we are inviting submissions investigating novel avenues for the prevention and treatment of cardiovascular diseases, including heart disease, diabetes, metabolic syndrome, and complications associated with these diseases, such as kidney and liver disease. Furthermore, we are interested in the discovery of novel biomarkers and potential treatment options involving personalised or alternative medicine. We invite submissions across the field of cardiovascular disease and metabolic research, as well as reviews or commentaries.
Prof. Dr. Tandi Matsha
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Applied Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diabetes
- heart disease
- MODY
- atherosclerosis
- ischemia
- cardiovascular disease therapy
- biomarkers
- miRNAs
- blood pressure
- HbA1c
- metabolic syndrome
- alternative medicine
- traditional medicine